Awarded

Vacunas inactivadas producidas a partir de virus crecidos en huevos embrionarios, de virus fraccionados o de antígenos de superficie (H y N), o análogas, de 15 microgramos de hemaglutinina de cada cepa incluida en la vacuna, con coadyuvante o análogas. 

Track this recordFree account — get alerted when a contract here runs out.
Contract value
no value published
Bids received
1
Published
1 Dec 2025
Awarded
12 Sept 2025
Contract start
12 Sept 2025
Contract end
13 Sept 2026estimated

More awards from this buyer